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When Cahan and his colleagues1,2 at the Memorial Sloan-Kettering Cancer Center of New York first systematized pneumonectomy, and later lobectomy, for lung cancer, 
they associated an intraoperative mediastinal lymph node assessment depending on the 
lobar location of the primary tumor as an ineludible maneuver in the surgical treatment 
of the disease. In Japan, the National Cancer Center of Tokyo was opened in 1962 to fight 
all types of cancer based on three fundamental principles: sound administration; compre-
hensive and multidisciplinary clinical care; and solid research. One of their projects for 
surgical treatment of cancers was the “evaluation of prognosis achieved by various kinds of 
surgical procedures combined with lymph node removal and adjuvant chemotherapy.”3 This 
principle was duly put into practice by the Japanese thoracic surgeons of that time and their 
followers.4,5 Since then, some intraoperative evaluation of the regional lymph nodes has 
been considered essential by individuals, working groups, and scientific societies to achieve 
a complete resection of lung cancer.6–9 However, although this practice has been followed 
strictly in Japan, where a lung resection without some sort of intraoperative mediastinal 
nodal assessment would be inconceivable, it has not permeated the thoracic surgical com-
munity in the United States beyond the institutions of excellence that give credit to North 
American medicine.
The article by Osarogiagbon and Yu,10 included in this issue, reports revealing results 
from the analysis of the Surveillance, Epidemiology and End Results database: 62% of 
patients with pathologic (p) N0 or pN1 non–small-cell lung cancer had no mediastinal 
lymph nodes examined at operation. This was after the exclusion of patients for whom 
mediastinal nodal examination could have been avoided, such as those undergoing explor-
atory thoracotomies. This is an astonishing fact: 7711 patients of 12,349 who underwent 
resection for lung cancer and were registered in the Surveillance, Epidemiology and End 
Results database between 1998 and 2002, had no mediastinal lymph nodes examined. In 
this population the absence of mediastinal nodal exploration was associated with a signifi-
cantly lower overall (52% versus 47%) and cancer-specific (63% and 58%) 5-year survival 
rates. Undoubtedly, this is, at least in part, because of the fact that some of the patients, 
whose tumors were classified as pN0 or pN1, had involved mediastinal lymph nodes that 
had passed unnoticed. Lack of exploration of these nodes prevents proper pathologic stag-
ing and the administration of adjuvant chemotherapy, which has proved to have an impact 
on prognosis.11
It would be presumptuous to pretend to identify the causes of this surgical failure 
from the other side of the Atlantic, but one can certainly speculate as Osarogiagbon and 
Yu10 have done: specialty training, surgical volume, hospital volume, teaching status, 
pathology practice. All this, however, can be traced back to education and training. If a 
thoracic surgeon is properly trained, or for that matter, if a general surgeon is properly 
trained in thoracic surgery and in the principles of oncologic surgery, the case volume, 
the type of practice, or the teaching status of the hospital should not be limiting factors 
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in performing some type of intraoperative assessment of the 
mediastinal lymph nodes. If the removed mediastinal lymph 
nodes are separated from the lung specimen, and properly 
labeled by the surgeon, the pathologists will find no difficulty 
in examining them and have no excuse to not examine them.
In such big countries and heterogeneous continents as 
the United States and Europe, differences in teaching pro-
grams and limited exposure to thoracic oncology issues during 
residency training may be the cause of suboptimal practice. 
In this case, the role of scientific societies is fundamental. In 
Spain, for example, the Spanish Society of Pneumology and 
Thoracic Surgery issued a consensus document with clear def-
initions and indications of the different types of intraoperative 
mediastinal exploration.12 In Europe, the European Society 
of Thoracic Surgeons, aware of the differences in health care 
systems, training and practice across the continent, published 
guidelines on types and indications of intraoperative medias-
tinal nodal assessment, to set the standard of the minimum 
required for routine clinical practice.9 The result is that there is 
a collective awareness that some sort of intraoperative medi-
astinal exploration is mandatory in most surgical candidates. 
Among the 24090 lung resections for lung cancer submit-
ted to the European Society of Thoracic Surgeons Thoracic 
Database by 220 thoracic surgery units, from 2007 to 2012, 
80% had systematic nodal dissection, 11% had other type of 
nodal assessment, and only 9% had either no sampling or the 
procedure was unknown.13 Intraoperative nodal assessment 
is important not only for identifying N2 disease and making 
postoperative therapeutic decisions, but also for proper defini-
tion of the absence of nodal involvement—the pN0 status.14 
In 1997, the International Association for the Study of Lung 
Cancer defined systematic nodal dissection in an international 
and multidisciplinary consensus meeting;15 and in 2005, it 
defined node-specific systematic nodal dissection.8 In either 
type of dissection, three mediastinal nodes and three hilar/
intrapulmonary nodes had to be retrieved for proper intraop-
erative nodal staging and definition of the pN0 status. Those 
who practice systematic nodal dissection routinely know that 
six nodes are a small number compared with the nodes that 
can be found in the mediastinum, but this standard was set to 
stimulate nodal exploration in lung cancer resection, and it is 
better than retrieving no mediastinal nodes at all.
Osarogiagbon and colleagues16,17 have a sharp eye in 
identifying failures in surgical and pathological practice, 
but they propose effective solutions too.18 It is this process 
of focused research on a specific problem, constructive criti-
cism, and proposal of solutions that makes improvement 
possible. Osarogiagbon and colleagues are dealing with a cru-
cial problem that affects the United States, and surely other 
countries, and are starting to solve it in their own institutions 
and  working groups. It would be desirable if professionals in 
other countries also followed their example and increase the 
rate of intraoperative mediastinal nodal exploration in every 
lung cancer resection performed with curative intent.
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